Home Ideas & Research Indexes Hedge Funds Portfolios My tickerspy Newswire
Enter ticker(s) QQQ: 62.94 -0.68%   SPY: 132.83 -0.38%
Profile Portfolio  


  Track this Pro and follow their portfolio moves with tickerspy™ alerts  

BB Biotech

  Performance       Similar Pro Portfolios       Community  
 
Today:
Week:
1-month:
All-time:
+0.2%
+3.7%
+16.3%
+32.8%
vs S&P 500:
vs S&P 500:
vs S&P 500:
vs S&P 500:
+0.6%
+6.0%
+20.8%
+36.6%
 

Data since: Jan-1-2008
Current Portfolio: Q4 2011


     
Third Security +0.3%
Perceptive Advi... +0.3%
Baker Bros. Adv... +1.4%
     
22 members Tracking
Share this Pro on Facebook
Share this Pro on Twitter
 
                     
     
 
Chart View
1 week
 
1 month
 
3 months
 
6 months
   
 
 

 
 
 
 
   
     
 
Portfolio Detail
 
  Standard View     Performance View    
Click a column to sort | Scroll over columns for more information
 
 Ticker Last Trade Today's Change Volume  % of
Daily
Mkt Cap  Div Yield  % off
52wk lw
% from
52wk hg
Q4 2011 View as: Alerts Holdings Detail
 ACHN $6.69 -0.13 -1.91% 398,585 34% $481.7M - 76% -48% -12.2% $16.0M | 2.1M shares - increase of 88.5K shares
 ALXN $86.99 +0.26 +0.30% 1,516,238 141% $16.2B - 99% -8% +21.7% $32.2M | 450.0K shares - No Change
 AMLN $27.54 +0.24 +0.88% 4,915,492 145% $4.4B - 243% 1% +142.0% $27.2M | 2.4M shares - No Change
 ARIA $17.52 +0.25 +1.45% 3,718,008 112% $2.8B - 132% 1% +43.0% $39.8M | 3.3M shares - New Holding
 BMRN $38.46 -0.32 -0.83% 1,223,828 112% $4.4B - 62% -1% +11.9% $33.5M | 975.5K shares - No Change
 CELG $70.72 -0.48 -0.67% 2,806,015 83% $31.1B - 37% -12% +4.6% $189.3M | 2.8M shares - decrease of 300.0K shares
 GILD $51.58 -0.29 -0.56% 6,719,997 81% $39.3B - 50% -9% +26.0% $80.2M | 2.0M shares - decrease of 640.0K shares
 HALO $7.45 +0.05 +0.68% 982,208 76% $837.4M - 34% -45% -21.7% $45.6M | 4.8M shares - decrease of 200.0K shares
 IDIX $9.12 +0.48 +5.56% 2,260,607 126% $987.9M - 126% -40% +22.5% $18.5M | 2.5M shares - No Change
 IMGN $13.65 -0.08 -0.58% 386,631 85% $1.0B - 49% -16% +17.9% $46.3M | 4.0M shares - No Change
 INCY $23.70 +0.95 +4.18% 2,094,895 128% $2.9B - 102% -2% +57.9% $76.0M | 5.1M shares - increase of 400.0K shares
 ISIS $9.23 +0.04 +0.44% 500,555 82% $924.6M - 48% -1% +28.0% $52.2M | 7.2M shares - increase of 1.6M shares
 OPTR $14.90 -0.38 -2.49% 680,202 88% $714.5M - 119% -17% +21.7% $17.7M | 1.4M shares - No Change
 THRX $21.44 -0.18 -0.83% 312,639 70% $1.8B - 66% -18% -3.0% $18.6M | 843.2K shares - No Change
 VRTX $62.61 -0.77 -1.21% 2,839,000 62% $13.3B - 136% -5% +88.5% $99.6M | 3.0M shares - increase of 273.0K shares
Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Close [X]  
Post a comment on this stock.
(250 character limit)

Make comment private

Delete Comment

Discuss BB Biotech's portfolio
 
Latest Portfolio Notes & Links
 
View: Headlines   |   Message Board   |   Portfolio Notes  
 
 
GlaxoSmithKline Completes Transaction to Increase Its Ownership in Theravance
THRX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 16, 09:17AM from (www.globenewswire.com)
LONDON and SOUTH SAN FRANCISCO, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc ("GSK") (LSE:GSK)  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
ACH-3102 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
ACHN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 15, 07:00AM from (www.globenewswire.com)
NEW HAVEN, Conn., May 15, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) announced today the receipt  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Amylin Said to Attract Interest From Pfizer, AstraZeneca
BMY  PFE  AMLN  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 14, 10:27PM from (www.bloomberg.com)
Amylin Pharmaceuticals Inc. CEO Bradbury


Daniel Bradbury, chief executive officer of Amylin Pharmaceuticals Inc.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Gilead's HIV Quad Pill Wins Backing From FDA Advisers
BMY  GILD  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 11, 02:57PM from (www.bloomberg.com)
Gilead Sciences Inc. (GILD)’s experimental HIV pill Quad, the new medicine from the world’s largest maker of AIDS drugs,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Gilead's Pill Wins U.S. Panel Backing to Prevent HIV
GILD  
Linked by Bloomberg ( track newsfeed | ignore newsfeed ) - May 10, 07:07PM from (www.bloomberg.com)
Gilead Sciences Inc. (GILD) won the backing of regulatory advisers for the first approval of a drug to prevent HIV infections in gay and bi-sexual men.
 more ...

Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Optimer Pharmaceuticals Reports First Quarter 2012 Financial Results
OPTR  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 10, 04:01PM

SAN DIEGO, May 10, 2012 /PRNewswire/ -- Optimer Pharmaceuticals,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks
LLY  BVTI  CLDX  IMGN  ARIA  NKTR  EXEL  PCYC  GNBT  SGEN  ARRY  DNDN  GHDX  ABPI  CYTR  GALE  NLNK  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 10, 12:02PM from (247wallst.com)
It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Achillion Reports First Quarter 2012 Financial Results
ACHN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 09, 04:05PM from (www.globenewswire.com)
NEW HAVEN, Conn., May 9, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a leader in the discovery  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Achillion Advances Second Generation Pan-Genotypic NS5A Inhibitor, ACH-3102, Into Clinical Development
ACHN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 09, 07:00AM from (www.globenewswire.com)
NEW HAVEN, Conn., May 9, 2012 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN) today announced that it has  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Theravance to Webcast 2012 Annual Meeting of Stockholders on May 15, 2012
THRX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 08, 04:05PM from (www.globenewswire.com)
SOUTH SAN FRANCISCO, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- Theravance, Inc. (Nasdaq:THRX) announced today that it will  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Biotechs Bucking The Dendreon Trap & Curse
AMGN  SVNT  VRTX  VVUS  ARNA  DNDN  ALNY  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 08, 01:15PM from (247wallst.com)
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BioMarin to Present at the Baird Growth Stock Conference
BMRN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 08, 09:00AM from (www.globenewswire.com)
NOVATO, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Hank Fuchs,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
BioMarin to Present at the Deutsche Bank Healthcare Conference
BMRN  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 08, 09:00AM from (www.globenewswire.com)
NOVATO, Calif., May 8, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Hank Fuchs,  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Isis Reports Financial Results and Highlights for First Quarter 2012
ISIS  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 08, 07:00AM

CARLSBAD, Calif., May 8, 2012 /PRNewswire/ -- Isis Pharmaceuticals,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Buffett Was a Buyer on Friday
TSN  VRTX  PETS  BSFT  
Linked by tickerspy Newswire ( track newsfeed | ignore newsfeed ) - May 07, 04:51PM from (www.tickerspy.com)
Stocks ended the day mixed following Friday's big sell-off. The market looked poised to continue the downward trend following  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
24/7 Wall St. Closing Bell
OMX  WEN  HFC  LPX  THC  PEP  PG  TSN  CDE  HL  CCL  VRTX  DIS  DISH  AWR  CTSH  ILMN  FSLR  BBEP  ANV  BSFT  CHTR  DMD  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 07, 04:08PM from (247wallst.com)
The major US stock indexes opened lower this morning following a weekend of elections in Europe. A new Socialist party president  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Halozyme Reports First Quarter 2012 Financial Results
HALO  
Posted by PR Newswire ( track newsfeed | ignore newsfeed ) - May 07, 04:05PM

SAN DIEGO, May 7, 2012 /PRNewswire/ -- Halozyme Therapeutics,  more ...
Flag Post a comment

Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Vertex Sees Billions In Value on Cystic Fibrosis Results
VRTX  
Linked by 24/7 Wall St. ( track newsfeed | ignore newsfeed ) - May 07, 08:54AM from (247wallst.com)
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is trading up so much higher that you might think the company is being  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
AstraZeneca Searches For Answers
FRX  AMGN  AMLN  AZN  
Linked by Investopedia Stock Analysis ( track newsfeed | ignore newsfeed ) - May 03, 10:02AM from (stocks.investopedia.com)
AstraZeneca has an opportunity to do something big when it brings in a new CEO.  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Idenix Pharmaceuticals Reports First Quarter 2012 Financial Results and HCV Development Program Progress
IDIX  
Linked by GlobeNewswire ( track newsfeed | ignore newsfeed ) - May 02, 04:05PM from (www.globenewswire.com)
CAMBRIDGE, Mass., May 2, 2012 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX), a biopharmaceutical company  more ...
Flag Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 80



Close [X]  
Post a description about this portfolio.
(150 character limit)

Click to close X

Use portfolios to track tickers you're interested in. News related to your tickers will appear below the portfolio. Tickers in your portfolios will generate Alerts on your tickerspy Alerts page.

The Recent Tickers portfolio saves the tickers you've recently viewed on the site.

Click to close X

By matching similar portfolios, tickerspy helps members find institutional and individual investors with strategies similar to their own.

Click to close X

Portfolio performance for tickerspy member portfolios is calculated by equally weighting all of the stocks held in the portfolio.

Click to close X

Performance View offers a snapshot of how individual portfolio positions have performed since being added (or shorted) as well as a look at the individual stocks' performance over various time periods. In the case of "shorts," a decline in price will result in a positive gain.

Portfolio History offers a view of all current and past holdings in a portfolio.

Click to close X

Institutional Holdings Disclaimer

Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter.

Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time.

tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors.

Click to close X

To calculate "all-time" Pro performance, we combine all of the quarterly holdings reports for that Pro investor. The initial date used is the start date of the first quarterly holdings report we have in our database. Start dates vary based on the first quarterly holdings report we have for each Pro. Please see our Institutional Holdings Disclaimer (located at the bottom of this page) for more on how we calculate Pro portfolio performance estimates. tickerspy is not affiliated with any of Pro investors profiled on our web site.

Click to close X

Your primary portfolio will appear in other member’s Tracking Hubs when they track your performance. Your primary portfolio is also used in our Ideas & Research section, where your portfolio is compared with the portfolios of other members, and elsewhere on the site where other portfolio comparisons are made.

Note: Primary portfolios must contain at least five stocks of greater than $1 per share. If you have elected to make your primary portfolio private or if your portfolio is not eligible to be primary, it will not appear in the Ideas & Research section or on the front page.

Click to close X

Primary portfolio

Click to close X
Click the Alerts links in your portfolio to see news from the last 36 hours as well as data alerts displaying unusual price and volume action. You will also see Alerts related to the activity of other tickerspy members. To see more Alerts, visit your customized Alerts page. And for more Alerts info, visit our Alerts FAQ.
Click to close X
The Recent Tickers portfolio saves the tickers you've recently viewed on the site.